Title21 Health Solutions is moving the needle in Transforming Healthcare
Top 10 Most Inspiring CEOs to Watch in 2022
The healthcare industry is now in the midst
of the most change its ever seen in its history. The technology wave that
has disrupted so many other industries has now descended on healthcare. One
such organization at the forefront and leading this change is Title21 Health
Solutions. Title21 has risen to a leadership position in the immunotherapy,
regenerative, and cell and gene therapy domains with their flexible, end-to-end
integrated software platform. Lynn Fischer, CEO of Title21 Health Solutions,
has some interesting insights to share from their successful journey.
About Title21 Health Solutions
For nearly 20 years, Title21 has been
providing easy-to-use, HIPAA-compliant software solutions targeting the
FDA-regulated domains. Having started with a suite of quality management
solutions for the blood industry, Title21 pivoted into the Cellular Therapy
market and has invested extensively to develop a leading platform targeting
both academic and cGMP manufacturing programs. These market segments are
demanding as they each require highly flexible solutions to accommodate their
complex and unique workflows. The Title21 system allow laboratory, clinical,
and manufacturing entities to be relieved of the many of the paperwork burdens
normally found in complex biologic processing, allowing them focus on higher-value
work, serving more patients with better safety, quality and efficiency.
Programs that implement Title21’s solutions find they can take products from
bench to bedside with less resources and higher throughput than ever before.
The Right Mix of Solutions
Title21’s product roadmap has been largely
driven by their customers and their need to meet cGMP\cGLP requirements. In
addition to supporting core Cell and Gene Manufacturing processes such as Lab
Processing, Collections, Reagent Manufacturing, CAR- T workflows, Chain of
Custody/Identity and Product Inventory, Title21 also offers a complete
Enterprise Quality Management system that includes Document Control, Error
Management and Learning and Competency Management, Audit, Corrective and
Preventive Action, Supplies, Equipment Maintenance and Calibration. Title21
enables manufacturing and healthcare teams to have patient, manufacturing and
quality data accessible in one system. With out-of-the-box integrated modules,
Title21 eliminates double-data entry, validates data and provides quick access
to any Batch record. Title21’s comprehensive interoperability capabilities
allow for data sharing with external systems like EPIC, Cerner, SAP and others
to provide seamless data flow across complex and disparate systems.
The Driving Factor
Title21 is aligned to the same drivers as
their customers; serving patients to the very best of their abilities. With
customer relationships built on this shared foundation of placing patient care
first, Title21 has developed many long-standing and strategic partnerships that
bring safety and innovation to the forefront. This approach has positioned
Title21 in the marketplace as a “go-to” solution for hospitals, Cell and Gene
Therapy Laboratories, and cGMP manufacturing facilities.
The Road Ahead
Title21’s mission is to serve the many
patients and their families who face life-threatening diseases by supporting
the leading healthcare institutions and biotech companies with powerful tools
that help them deliver innovative treatments. Every team member at Title21 is
dedicated to supporting the lifesaving work of these institutions and helping
them deliver on the promise of a new generation of curative therapies.